Immunohistochemistry (IHC) is a special test used by pathologists to detect specific molecules on cells. It is widely used in clinical oncology for categorizing solid cancer tumors and blood cancers, ...

Introduction A significant proportion of red blood cell (RBC) transfusions are administered intraoperatively; yet there is limited evidence to guide transfusion decisions in this setting. The ...

Step-Up Dosing Protocols and Infection Prevention Strategies for Bispecifics in B-Cell Lymphomas Author(s): Ryan Haumschild, PharmD, MS, MBA, CPEL , John Allan, MD ...

The Alfredson protocol is a treatment for Achilles tendonitis that involves repeated eccentric heel drop exercises. In this exercise, the heel is slowly lowered off a step while the toes stay on the ...

The authors propose that altered T-cell response plays a role in this process, shedding light on mechanisms that may be of interest to medical biologists, biochemists, cell biologists, and ...

Accompanied by six subsidiaries, the IHC delegation at WEF in Davos aims to drive leading conversations around transformational, future-ready solutions, creating value across sectors. The IHC House at ...

There was no particular sample selection methodology for this protocol ... (H) Tumor cells show strong (3+) membrane staining (arrows) with FGFR2b. FGFR2b, fibroblast growth factor receptor 2 isoform ...

Cancer cells can poison attacking immune cells by filling them with defective mitochondria ― dampening the body’s defensive forces and helping the tumour to evade eradication 1. These findings ...

On January 13, 2025, a study (DOI: 10.1038/s41413-024-00387-9) published in Bone Research introduced a newly optimized imaging protocol designed to visualize LepR + stromal cells within optically ...

In 2009 a team of biophysicists led by Anthony A. Hyman of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany, were studying specklelike structures called P ...

This valuable study reports the induction of supernumerary inner hair cells in the mouse cochlea upon reducing the expression level of a tight-junction protein (claudin-9) at developmental stages.